These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 29567356)
1. Anaphylaxis care guidelines and the effect on health care resource use in the United States. Song TT; Brown D; Lehnigk U; Corvino FA; Lieberman P Ann Allergy Asthma Immunol; 2018 Jul; 121(1):132-134.e3. PubMed ID: 29567356 [No Abstract] [Full Text] [Related]
2. Prevention of Anaphylaxis: The Role of the Epinephrine Auto-Injector. Fromer L Am J Med; 2016 Dec; 129(12):1244-1250. PubMed ID: 27555092 [TBL] [Abstract][Full Text] [Related]
3. Timing the transfer of responsibilities for anaphylaxis recognition and use of an epinephrine auto-injector from adults to children and teenagers: pediatric allergists' perspective. Simons E; Sicherer SH; Simons FE Ann Allergy Asthma Immunol; 2012 May; 108(5):321-5. PubMed ID: 22541402 [TBL] [Abstract][Full Text] [Related]
4. Out-of-Pocket Spending Among Commercially Insured Patients for Epinephrine Autoinjectors Between 2007 and 2014. Chua KP; Conti RM JAMA Intern Med; 2017 May; 177(5):736-739. PubMed ID: 28346591 [TBL] [Abstract][Full Text] [Related]
5. Retrospective study of drug-induced anaphylaxis treated in the emergency department or hospital: patient characteristics, management, and 1-year follow-up. Banerji A; Rudders S; Clark S; Wei W; Long AA; Camargo CA J Allergy Clin Immunol Pract; 2014; 2(1):46-51. PubMed ID: 24565768 [TBL] [Abstract][Full Text] [Related]
6. Epinephrine and its use in anaphylaxis: current issues. Simons KJ; Simons FE Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):354-61. PubMed ID: 20543673 [TBL] [Abstract][Full Text] [Related]
10. Epinephrine (adrenaline) in the first-aid, out-of-hospital treatment of anaphylaxis. Simons FE Novartis Found Symp; 2004; 257():228-43; discussion 243-7, 276-85. PubMed ID: 15025402 [TBL] [Abstract][Full Text] [Related]
11. Use of Epinephrine for Out-of-Hospital Treatment of Anaphylaxis. Prehosp Emerg Care; 2019; 23(4):592. PubMed ID: 30513053 [No Abstract] [Full Text] [Related]
12. Anaphylaxis: a payor's perspective on epinephrine autoinjectors. Dunn JD; Sclar DA Am J Med; 2014 Jan; 127(1 Suppl):S45-50. PubMed ID: 24384137 [TBL] [Abstract][Full Text] [Related]
13. Update on epinephrine for the treatment of anaphylaxis. Pongracic JA; Kim JS Curr Opin Pediatr; 2007 Feb; 19(1):94-8. PubMed ID: 17224669 [TBL] [Abstract][Full Text] [Related]
14. Lack of worldwide availability of epinephrine autoinjectors for outpatients at risk of anaphylaxis. Simons FE Ann Allergy Asthma Immunol; 2005 May; 94(5):534-8. PubMed ID: 15945555 [TBL] [Abstract][Full Text] [Related]
15. Use of epinephrine in the treatment of anaphylaxis. Lieberman P Curr Opin Allergy Clin Immunol; 2003 Aug; 3(4):313-8. PubMed ID: 12865777 [TBL] [Abstract][Full Text] [Related]
16. In brief: Auvi-Q--a new epinephrine auto-injector. Med Lett Drugs Ther; 2013 Feb; 55(1410):13. PubMed ID: 23459456 [No Abstract] [Full Text] [Related]
17. The diagnosis and management of anaphylaxis. Borchers AT; Naguwa SM; Keen CL; Gershwin ME Compr Ther; 2004; 30(2):111-20. PubMed ID: 15566107 [TBL] [Abstract][Full Text] [Related]